Specialities

Specialities

Bladder Cancer
Breast Cancer
Colorectal Cancer
COVID-19
Dermatological Cancers
Diagnostics and Screening
Gastrointestinal Cancers
Genitourinary Cancer
Gynaecological Cancers
Haematological Malignancies
Haematology
Head and Neck Cancer
Immunotherapy
Leukaemia
Lung Cancer
Lymphoma
Multiple Myeloma
Endocrine Cancers
Ovarian Cancer
Pancreatic Cancer
Paediatric Oncology
Policy
Prostate Cancer
Renal Cancer
Sarcoma
Supportive Cancer Care
Soft Tissue Tumours
Neuro-oncology
Radiology
Radiotherapy
Rare Diseases
Search

Trending Topic

3d illustration of human body liver
12 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Durvalumab for the Treatment of Advanced Biliary Tract Cancer

Allan A Lima Pereira, Gabriel Lenz, Tiago Biachi de Castria

Despite being considered a rare type of malignancy, constituting only 3% of all gastrointestinal cancers, the incidence of biliary tract cancers (BTCs) has been increasing worldwide in recent years, with about 20,000 new cases annually only in the USA.1–3 These cancers arise from the biliary epithelium of the small ducts in the periphery of the liver […]

touchREVIEWS in Oncology & Haematology. 2025;21(1):Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Global Forum on GU Oncology (RENALC-BLADDR-PROSCA 2024)

Global Forum on GU Oncology (RENALC-BLADDR-PROSCA 2024)
Web Address: Hybrid Global Forum on GU Oncology Website

RENALC’24, BLADDR’24 and PROSCA’24: 3 multidisciplinary, international meetings with a focus on the implications of new clinical findings on your daily practice.

When?

RENALC: 26 (PM) November 2024
BLADDR: 27 (full day) & 28 (AM) November 2024
PROSCA: 29 (full day) & 30 (AM) November 2024

Further Resources

  1. Hybrid Global Forum on GU Oncology
3d illustration of human body liver

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Durvalumab for the Treatment of Advanced Biliary Tract Cancer

Allan A Lima Pereira, Gabriel Lenz, Tiago Biachi de Castria

Despite being considered a rare type of malignancy, constituting only 3% of all gastrointestinal cancers, the incidence of biliary tract cancers (BTCs) has been increasing worldwide in recent years, with about 20,000 new cases annually only in the USA.1–3 These cancers arise from the biliary epithelium of the small ducts in the periphery of the liver […]

Advertisement

    • Latest articles videos and clinical updates - straight to your inbox

    Close Popup